NCT02105415View on ClinicalTrials.gov

"Ketamine / Propofol Admixture Ketofol at Induction in the Critically Ill Against Etomidate: KEEP PACE Trial"

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 28, 2017

Study Completion Date

August 1, 2018

Conditions
Critical Illness
Interventions
DRUG

Ketamine / Propofol Admixture

DRUG

Etomidate

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT02105415 - "Ketamine / Propofol Admixture Ketofol at Induction in the Critically Ill Against Etomidate: KEEP PACE Trial" | Biotech Hunter | Biotech Hunter